MicroStrategy
MSTR
英伟达
NVDA
Adobe
ADBE
赛富时
CRM
苹果
AAPL
美股市场个股详情
MBX MBX Biosciences
- 20.360
- +0.090+0.44%
收盘价 12/20 16:00 (美东)
- 20.360
- 0.0000.00%
盘后 16:20 (美东)
6.80亿总市值-12.32市盈率TTM
21.640最高价19.210最低价277.18万股成交量19.550今开20.270昨收5644.44万成交额27.18%换手率亏损市盈率(静)3341.74万总股本27.50052周最高2.51市净率2.08亿流通值15.31052周最低--股息TTM1020.00万流通股27.500历史最高--股息率TTM11.99%振幅15.310历史最低20.363平均价1股每手
MBX Biosciences所有资讯
MBX Biosciences | SC 13G：超过5%持股股东披露文件-Wellington Management Group LLP(9.22%),Wellington Group Holdings LLP(9.22%)等
MBX Biosciences | 10-Q：季度报表
MBX Biosciences | 8-K：MBX Biosciences公布2024年第三季度财务业绩并提供业务最新情况
MBX Biosciences | SC 13G：超过5%持股股东披露文件-P. Kent Hawryluk(5.55%)
MBX Biosciences | SC 13D：超过5%持股股东披露文件-Norwest Venture Partners XVI, LP(6.4%),Genesis VC Partners XVI, LLC(6.4%)等
MBX Biosciences | SC 13D：超过5%持股股东披露文件-New Enterprise Associates 17, L.P.(11.4%),NEA Partners 17, L.P.(11.4%)等
MBX Biosciences | SC 13D：超过5%持股股东披露文件-OrbiMed Advisors LLC(12.0%),OrbiMed Capital GP VII LLC(9.9%)等
MBX Biosciences | SC 13G：超过5%持股股东披露文件-Deep Track Capital, LP(9.48%),Deep Track Biotechnology Master Fund, Ltd.(9.48%)等
MBX Biosciences | SC 13D：超过5%持股股东披露文件-James N. Topper(18.8%),Patrick J. Heron(18.8%)等
MBX Biosciences | SC 13G：超过5%持股股东披露文件-Wellington Biomedical Innovation Master Investors (Cayman) II, L.P.(5.62%)
MBX Biosciences | 4：持股变动声明-董事 Mathers Edward T
MBX Biosciences | 4：持股变动声明-股东 BASKETT FOREST
MBX Biosciences | 4：持股变动声明-股东 Behbahani Ali
MBX Biosciences | 4：持股变动声明-股东 Chang Carmen
MBX Biosciences | 4：持股变动声明-股东 Florence Anthony A. Jr.
MBX Biosciences | 4：持股变动声明-股东 Makhzoumi Mohamad
MBX Biosciences | 4：持股变动声明-股东 Walker Paul Edward
MBX Biosciences | 4：持股变动声明-股东 Yang Rick
MBX Biosciences | 4：持股变动声明-股东 SANDELL SCOTT D
MBX Biosciences | 4：持股变动声明-董事 ORBIMED ADVISORS LLC
